ARTICLE | Distillery Therapeutics
Neurology
March 7, 2018 12:50 AM UTC
Cell culture, fruit fly and mouse studies suggest inhibiting KPNA3 could help treat spinocerebellar ataxia type 3 (SCA3), which is caused by mutant ATXN3 containing polyglutamine repeats that accumula...
BCIQ Company Profiles